American Journal of Physiology-Endocrinology and Metabolism · 2007 · 169 citations · 32 references
Life SciencesEndocrinologyNutritional SciencesAgingLipid BiochemistryMetabolic RegulationEarly-life NutritionInsulin ResistanceLipid MetabolismLipoprotein MetabolismMetabolic Liver DiseaseTriglyceride MetabolismDevelopmental Programming By NutritionHepatic Insulin ResistanceHepatic Steatosis AssessmentHepatic Triglyceride MetabolismLipid Metabolism EffectsLipid Metabolism PathwaysLipid Metabolism VariationMaternal Lipid Metabolism
The nutritional environment encountered during fetal life is strongly implicated as a determinant of lifelong metabolic capacity and risk of disease. Pregnant rats were fed a control or low-protein (LP) diet, targeted to early (LPE), mid-(LPM), or late (LPL) pregnancy, or throughout gestation (LPA). The offspring were studied at 1, 9, and 18 mo of age. All LP-exposed groups had similar plasma triglyceride, cholesterol, glucose, and insulin concentrations to those of controls at 1 and 9 mo of age, but by 18 mo there was evidence of LP-programmed hypertriglyceridemia and insulin resistance. All LP-exposed groups exhibited histological evidence of hepatic steatosis and were found to have two- to threefold more hepatic triglyceride than control animals. These phenotypic changes were accompanied by age-related changes in mRNA and protein expression of the transcription factors SREBP-1c, ChREBP, PPARgamma, and PPARalpha and their respective downstream target genes ACC1, FAS, L-PK, and MCAD. At 9 mo of age, the LP groups exhibited suppression of the SREBP-1c-related lipogenic pathway but between 9 and 18 mo underwent a switch to increased lipogenic capacity with a lower expression of PPARgamma and MCAD, consistent with reduced lipid oxidation. The findings indicate that prenatal protein restriction programs development of a metabolic syndrome-like phenotype that develops only with senescence. The data implicate altered expression of SREBP-1c and ChREBP as key mediators of the programmed phenotype, but the basis of the switch in metabolic status that occurred between 9 and 18 mo of age is, as yet, unidentified.
32
Karen A. Lillycrop, Emma Phillips, Alan A. Jackson et al. · Journal of Nutrition · 2005 · 1.1K citations
Early growth and coronary heart disease in later life: longitudinal study
Johan G. Eriksson · BMJ · 2001 · 1K citations · Full text